These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5824354)

  • 21. [An electroencephalographic analysis of the anti-ischemic properties of amiridin].
    Buroiv IuV; Kaplan AIa
    Eksp Klin Farmakol; 1993; 56(6):4-5. PubMed ID: 8111297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine.
    Miyazaki M
    Jpn Circ J; 1971 Sep; 35(9):1053-7. PubMed ID: 5172103
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 25. Multifocal infarct dementia treated by cyclandelate and monitored by quantitative EEG.
    Harding GF; Hall P; Young J; Smith GA
    Angiology; 1978 Feb; 29(2):139-40. PubMed ID: 347986
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasodilators in geriatric psychiatry.
    Birkett DP
    J Med Soc N J; 1971 Aug; 68(8):619-23. PubMed ID: 4939868
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies].
    Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A
    Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709
    [No Abstract]   [Full Text] [Related]  

  • 28. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasodilators in prevention and treatment of ischemic stroke.
    Taylor JR
    J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium modulation and clinical effect. Profile of cyclandelate.
    Timmerman H
    Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of tritiated cyclandelate (3,5,5-trimethylcyclohexyl mandelate)-a vasoactive drug: preliminary observations by liquid scintillation spectrometry.
    Orr A; Whittier JR
    Int J Nucl Med Biol; 1974 Jun; 1(4):205-13. PubMed ID: 4435997
    [No Abstract]   [Full Text] [Related]  

  • 32. Observations on the effects of nicotinic acid, Cyclospasmol and Ronicol on the electrocortical activity and automatic movement of the rat.
    Singh R
    Curr Mod Biol; 1971 Feb; 3(4):323-31. PubMed ID: 5550387
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of cyclandelate vaso-active properties by the measure of the ear-retina time in the rabbit (author's transl)].
    Andermann C; Andermann G; Ehinger C
    Ann Pharm Fr; 1980; 38(3):253-60. PubMed ID: 7425477
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of a vasoactive drug (nylidrin HCl) on the response of the electroencephalogram to hyperventilation.
    Korein J; Geller M; Rosenblum WI; Levidow L
    Arch Neurol; 1966 Feb; 14(2):202-7. PubMed ID: 4952446
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic cerebrovascular disorders: a clinical study with cyclandelate.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L
    Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of cyclandelate on dementia.
    Westreich G; Alter M; Lundgren S
    Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral vasodilators.
    Hall P
    Br Med J; 1971 Aug; 3(5770):374. PubMed ID: 5558206
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of cyclandelate on diabetic peripheral neuropathy.
    Canal N; Comi G; Marchettini P; Pozza G
    Br J Clin Pract Suppl; 1984; 34():62-8. PubMed ID: 6430326
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of human platelet aggregation by cyclandelate.
    Van den Hoven WE; Hall DW
    Br J Clin Pract Suppl; 1984; 34():34-8. PubMed ID: 6430321
    [No Abstract]   [Full Text] [Related]  

  • 40. Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine. Report on 3 cases.
    Böker DK; Solymosi L; Wassmann H
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():118-20. PubMed ID: 4010867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.